IRIS
DOTTA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.637
EU - Europa 11.682
AS - Asia 2.149
AF - Africa 49
SA - Sud America 35
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 12
Totale 29.591
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.599
GB - Regno Unito 3.118
IE - Irlanda 2.035
IT - Italia 1.677
CN - Cina 1.398
UA - Ucraina 1.232
SE - Svezia 973
RU - Federazione Russa 829
FR - Francia 575
DE - Germania 538
SG - Singapore 433
FI - Finlandia 326
ES - Italia 138
VN - Vietnam 100
BE - Belgio 78
IN - India 62
TR - Turchia 42
NL - Olanda 39
CI - Costa d'Avorio 36
CA - Canada 31
AU - Australia 25
KR - Corea 20
CZ - Repubblica Ceca 19
PK - Pakistan 17
IR - Iran 14
BR - Brasile 13
JP - Giappone 13
CH - Svizzera 12
EU - Europa 12
GR - Grecia 12
HU - Ungheria 12
DK - Danimarca 11
HK - Hong Kong 10
PL - Polonia 10
RO - Romania 10
PT - Portogallo 8
PE - Perù 7
EC - Ecuador 6
AT - Austria 5
CL - Cile 5
EG - Egitto 5
IL - Israele 5
LT - Lituania 5
ID - Indonesia 4
JO - Giordania 4
MX - Messico 4
CO - Colombia 3
DZ - Algeria 3
IM - Isola di Man 3
IQ - Iraq 3
LU - Lussemburgo 3
NG - Nigeria 3
SA - Arabia Saudita 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
CY - Cipro 2
EE - Estonia 2
KW - Kuwait 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 29.591
Salva come PNG Salva come JPEG
Città #
Southend 2.888
Fairfield 2.662
Dublin 2.018
Houston 1.599
Ashburn 1.319
Chandler 1.256
Woodbridge 1.186
Jacksonville 997
Seattle 986
Wilmington 944
Cambridge 901
Ann Arbor 547
Princeton 455
Siena 455
Nanjing 352
Beijing 289
Singapore 285
Florence 173
Boardman 170
New York 145
San Diego 142
Helsinki 133
San Mateo 132
Nanchang 124
Málaga 122
Dong Ket 99
Moscow 89
Shanghai 76
Milan 69
Shenyang 65
Rome 63
Changsha 60
Munich 55
Hebei 54
Tianjin 54
Dearborn 51
Jiaxing 49
Kunming 46
London 42
Brussels 39
Atlanta 38
Falls Church 38
Norwalk 37
Abidjan 36
Zhengzhou 34
Washington 29
Fremont 28
Leuven 27
Los Angeles 26
Izmir 25
Ningbo 24
San Francisco 24
Hangzhou 21
Jinan 21
Guangzhou 20
Brno 18
Pisa 18
Toronto 18
Düsseldorf 17
Phoenix 16
Venezia 16
Saronno 15
Edinburgh 14
Redwood City 14
Santa Clara 14
Palermo 13
Tappahannock 13
Amsterdam 12
Budapest 12
Dallas 12
Prato 12
Verona 12
Napoli 11
Redmond 11
Taizhou 11
Chicago 10
Hefei 10
Bari 9
Bologna 9
Changchun 9
Kraainem 9
Lanzhou 9
Melbourne 9
Copenhagen 8
Enfield 8
Kilburn 8
Lastra a Signa 8
Mori 8
Padova 8
Prescot 8
Udine 8
Vaiano 8
Warsaw 8
Chiswick 7
Columbus 7
Frankfurt am Main 7
Karachi 7
Poggibonsi 7
Stockholm 7
Bergamo 6
Totale 22.100
Salva come PNG Salva come JPEG
Nome #
Markers of beta cell function in type 1 diabetes mellitus 572
null 398
Urban diabetes: The case of the metropolitan area of Rome 393
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. 276
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 222
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 211
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 207
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 202
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 199
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 195
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 190
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 190
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 189
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 186
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 183
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 182
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 181
Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes 181
MicroRNAs: markers of β-cell stress and autoimmunity 181
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 179
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 178
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 177
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 172
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 171
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 170
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 166
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 166
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 166
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 166
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 164
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 163
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study 163
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 163
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 161
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 157
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 157
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 155
Endocrine actions of osteocalcin 155
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 153
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 148
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 147
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 144
Coxsackieviruses and Insulitis 143
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 143
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 143
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 142
Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells 141
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial 141
Incretin Hormones and Beta-cell mass expansion: what we know and what is missing? 140
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 140
Enteroviral Infections and Development of Type 1 Diabetes: The Brothers Karamazov Within the CVBs 140
Prognostic bioindicators in severe COVID-19 patients 139
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset 138
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus. 137
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 137
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 137
Guidelines for the treatment and management of new-onset diabetes after transplantation 136
The case for virus-induced type 1 diabetes 136
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 136
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 136
Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. 134
Assay for cytoplasmic islet cell antibodies using two-color immunofluorescence and rat pancreas 134
Viral Infections and diabetes 134
Dietary supplementation with high doses of regular vitamin D3 safely reduces Diabetes incidence in nod mice when given early and long-term. 134
Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes 133
Fighting diabetic foot ulcers—The diabetologist: A king maker of the fight 133
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 132
Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. 131
Optimizing insulin glargine plus one injection of insulin glulisine in type 2 diabetes in the ELEONOR study: similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction. 131
Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. 131
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans 130
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial 130
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy 129
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010" 129
Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: Results from the prospective European Exenatide (EUREXA) study 129
Virus infections: lessons from pancreas histology 129
IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes 128
null 128
Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets 127
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease 127
An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment 126
Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study-the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study 125
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 125
In type 1 diabetes immunocompetent cells are defective in IL-16 secretion 124
Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. 124
Type VII collagen in Alport syndrome 124
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. 123
Can NK cells be a therapeutic target in human type 1 diabetes? 123
Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects 123
Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. 123
Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets 123
CD4+CD25high regulatory T cells in human autoimmune diabetes 122
The acquisition of an insulin-secreting phenotype by HGF-treated rat pancreatic ductal cells (ARIP) is associated with the development of susceptibility to cytokine-induced apoptosis. 122
Pathological changes in human insulitis 122
Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study 122
Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases? 121
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 121
Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependent 121
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. 120
Autoantigens in thyroid and islet autoimmunity: similarities and differences 120
Totale 15.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.652
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.274 0 0 0 0 586 556 609 861 574 533 189 366
2020/20214.776 194 600 160 472 351 478 234 703 530 372 344 338
2021/20223.296 260 556 209 289 117 101 173 105 145 317 320 704
2022/20234.482 282 318 472 645 475 929 66 353 474 165 192 111
2023/20243.121 149 109 245 133 160 843 967 99 25 124 39 228
2024/20251.809 133 387 620 430 239 0 0 0 0 0 0 0
Totale 30.282